Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Karel Dicke"'
Autor:
Jayne Gurtler, Andrew H. Ko, Terry Katz, Mark Keaton, Eric K. Rowinsky, Hagop Youssoufian, Omar Kayaleh, Heinz-Josef Lenz, Shaila Ballal, Karel Dicke
Publikováno v:
Investigational New Drugs. 30:1597-1606
The purpose of this study was to assess the efficacy and safety of bevacizumab plus cetuximab with or without gemcitabine in patients with advanced pancreatic adenocarcinoma. Patients with locally advanced or metastatic pancreatic adenocarcinoma, pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::666f34b0c46600181d0d6989c036e6b9
https://doi.org/10.1007/s10637-011-9691-8
https://doi.org/10.1007/s10637-011-9691-8
Autor:
Sundar Jagannath, Bart Barlogie, Leslie Smallwood, Bruce Cheson, Kimberly Pruitt, Frederick C. Lemaistre, Raymond Alexanian, Gunnar Zagars, Karel Dicke, Dennis O. Dixon
Publikováno v:
Blood. 76:1860-1866
Multiple myeloma remains a universally fatal malignancy with a median survival time not exceeding 3 years. A clinical trial was undertaken to determine feasibility and efficacy of marrow-ablative chemoradiotherapy supported by unpurged autologous bon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f92eb27bc11911ba8c1fdbc5c1ec56
https://doi.org/10.1182/blood.v76.9.1860.1860
https://doi.org/10.1182/blood.v76.9.1860.1860